Dapagliflozin
Generic name: Pronounced as (dap'' a gli floe' zin)
Medical Content Reviewed By HelloPharmacist Staff
Last Revised - 07/15/2021
On this page
- Why is this medication prescribed?
- How should this medicine be used?
- Other uses for this medicine
- What special precautions should I follow?
- What special dietary instructions should I follow?
- What should I do if I forget a dose?
- What side effects can this medication cause?
- What should I know about STORAGE and DISPOSAL of this medication?
- What should I do in case of OVERDOSE?
- What OTHER INFORMATION should I know?
- Brand names of combination products
- Drug interactions
Why is this medication prescribed?
Dapagliflozin is used along with diet and exercise, and sometimes with other medications, to lower blood sugar levels in adults with type 2 diabetes (condition in which blood sugar is too high because the body does not produce or use insulin normally). It is also used to reduce the risk of needing to be hospitalized for heart failure in adults who have type 2 diabetes along with heart and blood vessel disease or who have multiple risk factors for developing heart and blood vessel disease. Dapagliflozin is also used in adults with heart failure to reduce the risk of needing to be hospitalized and death due to heart and blood vessel disease. It is also used to reduce the risk of worsening kidney disease, the need to be hospitalized for heart failure, and the risk of death due to heart disease in adults with kidney disease. Dapagliflozin is in a class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors. It lowers blood sugar by causing the kidneys to get rid of more glucose in the urine. Dapagliflozin is not used to treat type 1 diabetes (condition in which the body does not produce insulin and, therefore, cannot control the amount of sugar in the blood) or diabetic ketoacidosis (a serious condition that may develop if high blood sugar is not treated).
Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems. Taking dapagliflozin, making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease. Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes.
How should this medicine be used?
Dapagliflozin comes as a tablet to take by mouth. It is taken usually with or without food once a day. Take dapagliflozin at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take dapagliflozin exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Your doctor may start you on a low dose of dapagliflozin and increase your dose if needed.
Dapagliflozin helps to control your condition, but does not cure it. Continue to take dapagliflozin even if you feel well. Do not stop taking dapagliflozin without talking to your doctor.
Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with dapagliflozin and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) to obtain the Medication Guide.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking dapagliflozin,
-
tell your doctor and pharmacist if you are allergic to dapagliflozin, any other medications, or any of the ingredients in dapagliflozin tablets. Ask your pharmacist or check the Medication Guide for a list of the ingredients.
-
tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: angiotensin-converting enzyme (ACE) inhibitors such as benazepril (Lotensin, in Lotrel), captopril, enalapril (Vasotec, in Vaseretic), fosinopril, lisinopril (in Zestoretic), moexipril (Univasc, in Uniretic), perindopril (Aceon, in Prestalia), ramipril (Altace), and trandolapril (Mavik, in Tarka); angiotensin receptor blockers (ARB) such as azilsartan (Edarbi, in Edarbyclor), candesartan (Atacand, in Atacand HCT), eprosartan (Teveten), irbesartan (Avapro, in Avalide), losartan (Cozaar, in Hyzaar), olmesartan (Benicar, in Azor, in Benicar HCT, in Tribenzor), telmisartan (Micardis, in Micardis HCT, in Twynsta); aspirin and other nonsteroidal anti-inflammatory medications (NSAIDS) such as ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn); diabetes medications such as glimepiride (Amaryl, in Duetact), glipizide (Glucotrol), glyburide (DiaBeta, Glynase), repaglinide (Prandin, in Prandimet), and tolbutamide; diuretics ('water pills'); and insulin.
-
tell your doctor if you are on dialysis. Your doctor may tell you not to take dapagliflozin.
-
tell your doctor if you regularly drink alcohol or sometimes drink large amounts of alcohol in a short time (binge drinking) or if you are on a low sodium diet. Also tell your doctor if you have or have ever had heart failure, pancreatic disease including pancreatitis (swelling of the pancreas) or have had surgery on your pancreas, urinary tract infections or problems urinating, low blood pressure, yeast infections in the genital area, kidney or liver disease. If you are male, tell your doctor if you have never been circumcised. Also, tell your doctor, if you are eating less due to illness, surgery or a change in your diet, or have recently had diarrhea, vomiting, not been drinking enough fluids, been in the sun too long, or have been sweating a lot, which may cause dehydration (loss of a large amount of body fluids).
-
tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. Do not breastfeed while you are taking dapagliflozin. If you become pregnant while taking dapagliflozin, call your doctor.
-
if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking dapagliflozin. Your doctor will probably tell you to stop taking dapagliflozin at least 3 days before a surgery.
-
alcohol may cause a change in blood sugar. Ask your doctor about the safe use of alcoholic beverages while you are taking dapagliflozin.
-
you should know that dapagliflozin may cause dizziness, lightheadedness, and fainting when you get up too quickly from a lying position. If you have this problem, call your doctor. This problem is more common when you first start taking dapagliflozin. To avoid this problem, get out of bed slowly, resting your feet on the floor for a few minutes before standing up.
-
ask your doctor what to do if you get sick, develop an infection or fever, experience unusual stress, or are injured. These conditions can affect your blood sugar and the amount of dapagliflozin you may need.
What special dietary instructions should I follow?
Be sure to follow all exercise and dietary recommendations made by your doctor or dietitian. It is important to eat a healthful diet and exercise regularly.
Follow your doctor's instructions about drinking enough fluids throughout the day while you are on this medication.
What should I do if I forget a dose?
Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
This medication may cause changes in your blood sugar. You should know the symptoms of low and high blood sugar and what to do if you have these symptoms.
-
Dapagliflozin may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
-
-
urinating a lot, including at night
-
increased thirst
-
-
Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately:
-
frequent, urgent, burning, or painful urination
-
urine that is cloudy, red, pink, or brown
-
strong smelling urine
-
decrease in amount of urine
-
pelvic or rectal pain
-
(in women) vaginal odor, white or yellowish vaginal discharge (may be lumpy or look like cottage cheese), or vaginal itching
-
(in men) redness, itching, or swelling of the penis; rash on the penis; foul smelling discharge from the penis; or pain in the skin around the penis
-
feeling tired, weak, or uncomfortable; along with a fever and pain, tenderness, redness, and swelling of the genitals or the area between the genitals and the rectum
-
swelling of the legs or feet
-
-
If you experience any of the following symptoms, stop taking dapagliflozin and call your doctor immediately or get emergency medical treatment:
-
rash
-
hives
-
itching
-
difficulty breathing or swallowing
-
swelling of the face, throat, tongue, lips, mouth, or eyes
-
hoarseness
-
-
If you experience any of the following symptoms of ketoacidosis, stop taking dapagliflozin and call your doctor immediately or get emergency medical treatment. If possible, check for ketones in your urine if you have these symptoms, even if your blood sugar is less than 250 mg/dL:
-
nausea
-
vomiting
-
stomach-area pain
-
tiredness
-
difficulty breathing
-
-
Dapagliflozin may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
-
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
What should I know about STORAGE and DISPOSAL of this medication?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).
It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org
Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.
What should I do in case of OVERDOSE?
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
What OTHER INFORMATION should I know?
Keep all appointments with your doctor and the laboratory. Your doctor will probably order certain laboratory tests before and during your treatment to check your body's response to dapagliflozin.
Your blood sugar levels should be checked regularly to determine your response to dapagliflozin. Your doctor will order other lab tests, including glycosylated hemoglobin (HbA1c), to check your response to dapagliflozin. Your doctor will also tell you how to check your response to this medication by measuring your blood sugar levels at home. Follow these instructions carefully.
Before having any laboratory test, tell your doctor and the laboratory personnel that you are taking dapagliflozin. Because of the way this medication works, your urine may test positive for glucose.
You should always wear a diabetic identification bracelet to be sure you get proper treatment in an emergency.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Drug interactions
Drug | Interaction |
---|---|
Moxifloxacin | Moxifloxacin The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Moxifloxacin. |
Repaglinide | Repaglinide Dapagliflozin may increase the hypoglycemic activities of Repaglinide. |
Montelukast | Montelukast The metabolism of Dapagliflozin can be decreased when combined with Montelukast. |
Insulin Glargine (rDNA origin) Injection | Insulin Glargine (rDNA origin) Injection Dapagliflozin may increase the hypoglycemic activities of Insulin glargine. |
Leflunomide | Leflunomide The serum concentration of Dapagliflozin can be decreased when it is combined with Leflunomide. |
Delavirdine | Delavirdine The metabolism of Dapagliflozin can be decreased when combined with Delavirdine. |
Nevirapine | Nevirapine The metabolism of Dapagliflozin can be decreased when combined with Nevirapine. |
Dolasetron | Dolasetron The metabolism of Dapagliflozin can be decreased when combined with Dolasetron. |
Aminophylline | Aminophylline The metabolism of Aminophylline can be decreased when combined with Dapagliflozin. |
Anagrelide | Anagrelide The metabolism of Anagrelide can be decreased when combined with Dapagliflozin. |
Bisacodyl | Bisacodyl The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Bisacodyl. |
Candesartan | Candesartan The metabolism of Dapagliflozin can be decreased when combined with Candesartan. |
Cilostazol | Cilostazol The metabolism of Cilostazol can be decreased when combined with Dapagliflozin. |
Clopidogrel | Clopidogrel The metabolism of Clopidogrel can be decreased when combined with Dapagliflozin. |
Diphenoxylate | Diphenoxylate The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Diphenoxylate. |
Estrogen and Progestin (Oral Contraceptives) | Estrogen and Progestin (Oral Contraceptives) The metabolism of Conjugated estrogens can be decreased when combined with Dapagliflozin. |
Fenofibrate | Fenofibrate The metabolism of Dapagliflozin can be decreased when combined with Fenofibrate. |
Guanfacine | Guanfacine Dapagliflozin may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy. |
Magnesium Hydroxide | Magnesium Hydroxide The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Magnesium hydroxide. |
Magnesium Oxide | Magnesium Oxide The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Magnesium oxide. |
Miglitol | Miglitol Dapagliflozin may increase the hypoglycemic activities of Miglitol. |
Mycophenolate | Mycophenolate Dapagliflozin may increase the excretion rate of Mycophenolic acid which could result in a lower serum level and potentially a reduction in efficacy. |
Olsalazine | Olsalazine Olsalazine may increase the hypoglycemic activities of Dapagliflozin. |
Paregoric | Paregoric The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Morphine. |
Penbutolol | Penbutolol The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Acebutolol. |
Pentazocine | Pentazocine The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Pentazocine. |
Polyethylene glycol-electrolyte solution (PEG-ES) | Polyethylene glycol-electrolyte solution (PEG-ES) The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Polyethylene glycol. |
Potassium | Potassium Dapagliflozin may increase the excretion rate of Potassium cation which could result in a lower serum level and potentially a reduction in efficacy. |
Prednisone | Prednisone The risk or severity of hyperglycemia can be increased when Prednisone is combined with Dapagliflozin. |
Psyllium | Psyllium The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Plantago seed. |
Ranitidine | Ranitidine The metabolism of Ranitidine can be decreased when combined with Dapagliflozin. |
Reserpine | Reserpine Dapagliflozin may increase the excretion rate of Reserpine which could result in a lower serum level and potentially a reduction in efficacy. |
Rizatriptan | Rizatriptan Dapagliflozin may increase the excretion rate of Rizatriptan which could result in a lower serum level and potentially a reduction in efficacy. |
Sumatriptan | Sumatriptan The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Sumatriptan. |
Tacrolimus | Tacrolimus The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Tacrolimus. |
Tizanidine | Tizanidine The metabolism of Tizanidine can be decreased when combined with Dapagliflozin. |
Triamcinolone | Triamcinolone The risk or severity of hyperglycemia can be increased when Triamcinolone is combined with Dapagliflozin. |
Zolmitriptan | Zolmitriptan The metabolism of Zolmitriptan can be decreased when combined with Dapagliflozin. |
Ampicillin Injection | Ampicillin Injection Dapagliflozin may increase the excretion rate of Ampicillin which could result in a lower serum level and potentially a reduction in efficacy. |
Doxycycline Injection | Doxycycline Injection Dapagliflozin may increase the excretion rate of Doxycycline which could result in a lower serum level and potentially a reduction in efficacy. |
Famotidine Injection | Famotidine Injection The metabolism of Dapagliflozin can be decreased when combined with Famotidine. |
Fluconazole Injection | Fluconazole Injection The risk or severity of hypoglycemia can be increased when Dapagliflozin is combined with Fluconazole. |
Hydromorphone Injection | Hydromorphone Injection The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Hydromorphone. |
Interferon Beta-1b Injection | Interferon Beta-1b Injection The metabolism of Dapagliflozin can be decreased when combined with Interferon beta-1b. |
Interferon Gamma-1b Injection | Interferon Gamma-1b Injection The metabolism of Dapagliflozin can be decreased when combined with Interferon gamma-1b. |
Levofloxacin Injection | Levofloxacin Injection The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Levofloxacin. |
Meperidine Injection | Meperidine Injection The metabolism of Dapagliflozin can be increased when combined with Meperidine. |
Methylprednisolone Injection | Methylprednisolone Injection The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Dapagliflozin. |
Metoclopramide Injection | Metoclopramide Injection The metabolism of Dapagliflozin can be decreased when combined with Metoclopramide. |
Metronidazole Injection | Metronidazole Injection The metabolism of Dapagliflozin can be decreased when combined with Metronidazole. |
Morphine Injection | Morphine Injection The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Morphine. |
Vancomycin Injection | Vancomycin Injection Dapagliflozin may increase the excretion rate of Vancomycin which could result in a lower serum level and potentially a reduction in efficacy. |
Zidovudine Injection | Zidovudine Injection The metabolism of Dapagliflozin can be decreased when combined with Zidovudine. |
Altretamine | Altretamine Amphetamine may increase the orthostatic hypotensive activities of Dapagliflozin. |
Cyclosporine | Cyclosporine The metabolism of Cyclosporine can be decreased when combined with Dapagliflozin. |
Ondansetron | Ondansetron The metabolism of Dapagliflozin can be decreased when combined with Ondansetron. |
Torsemide | Torsemide The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Torasemide. |
Olanzapine | Olanzapine The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Olanzapine. |
Alosetron | Alosetron The metabolism of Alosetron can be decreased when combined with Dapagliflozin. |
Entacapone | Entacapone The metabolism of Dapagliflozin can be decreased when combined with Entacapone. |
Eprosartan | Eprosartan The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Eprosartan. |
Hydroxychloroquine | Hydroxychloroquine The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Hydroxychloroquine. |
Meloxicam | Meloxicam The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Meloxicam. |
Pantoprazole | Pantoprazole Dapagliflozin may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy. |
Telmisartan | Telmisartan The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Telmisartan. |
Temozolomide | Temozolomide Dapagliflozin may increase the excretion rate of Temozolomide which could result in a lower serum level and potentially a reduction in efficacy. |
Zaleplon | Zaleplon Dapagliflozin may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy. |
Anakinra | Anakinra The metabolism of Dapagliflozin can be increased when combined with Anakinra. |
Linezolid | Linezolid Linezolid may increase the orthostatic hypotensive activities of Dapagliflozin. |
Trimipramine | Trimipramine The metabolism of Dapagliflozin can be decreased when combined with Trimipramine. |
Etanercept Injection | Etanercept Injection The metabolism of Dapagliflozin can be increased when combined with Etanercept. |
Modafinil | Modafinil The metabolism of Dapagliflozin can be increased when combined with Modafinil. |
Perindopril | Perindopril The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Dapagliflozin is combined with Perindopril. |
Tenofovir | Tenofovir Dapagliflozin may increase the excretion rate of Tenofovir which could result in a lower serum level and potentially a reduction in efficacy. |
Sirolimus | Sirolimus The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Sirolimus. |
Epinephrine Injection | Epinephrine Injection The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Epinephrine. |
Eplerenone | Eplerenone The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Eplerenone. |
Escitalopram | Escitalopram The serum concentration of Dapagliflozin can be increased when it is combined with Escitalopram. |
Olmesartan | Olmesartan The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Olmesartan. |
Zonisamide | Zonisamide The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Zonisamide. |
Adalimumab Injection | Adalimumab Injection The metabolism of Dapagliflozin can be increased when combined with Adalimumab. |
Aripiprazole | Aripiprazole The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Aripiprazole. |
Atomoxetine | Atomoxetine Dapagliflozin may increase the excretion rate of Atomoxetine which could result in a lower serum level and potentially a reduction in efficacy. |
Atazanavir | Atazanavir The metabolism of Dapagliflozin can be decreased when combined with Atazanavir. |
Almotriptan | Almotriptan Dapagliflozin may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy. |
Eletriptan | Eletriptan The metabolism of Dapagliflozin can be increased when combined with Eletriptan. |
Mefloquine | Mefloquine The metabolism of Dapagliflozin can be decreased when combined with Mefloquine. |
Polyethylene Glycol 3350 | Polyethylene Glycol 3350 The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Polyethylene glycol. |
Rosuvastatin | Rosuvastatin The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Rosuvastatin. |
Vardenafil | Vardenafil The risk or severity of hypotension can be increased when Vardenafil is combined with Dapagliflozin. |
Aprepitant | Aprepitant The metabolism of Dapagliflozin can be decreased when combined with Aprepitant. |
Emtricitabine | Emtricitabine Dapagliflozin may increase the excretion rate of Emtricitabine which could result in a lower serum level and potentially a reduction in efficacy. |
Interferon Beta-1a Subcutaneous Injection | Interferon Beta-1a Subcutaneous Injection The metabolism of Dapagliflozin can be decreased when combined with Interferon beta-1a. |
Memantine | Memantine Memantine may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Tegaserod | Tegaserod The metabolism of Dapagliflozin can be decreased when combined with Tegaserod. |
Tadalafil | Tadalafil Dapagliflozin may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy. |
Fosamprenavir | Fosamprenavir The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Fosamprenavir. |
Frovatriptan | Frovatriptan The metabolism of Frovatriptan can be decreased when combined with Dapagliflozin. |
Gemifloxacin | Gemifloxacin The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Gemifloxacin. |
Progesterone | Progesterone The metabolism of Dapagliflozin can be decreased when combined with Progesterone. |
Apomorphine Injection | Apomorphine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Dapagliflozin. |
Infliximab Injection | Infliximab Injection The metabolism of Dapagliflozin can be increased when combined with Infliximab. |
Oxandrolone | Oxandrolone The metabolism of Dapagliflozin can be decreased when combined with Oxandrolone. |
Protriptyline | Protriptyline Protriptyline may decrease the hypoglycemic activities of Dapagliflozin. |
Duloxetine | Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Dapagliflozin is combined with Duloxetine. |
Norethindrone | Norethindrone The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Norethisterone. |
Tinidazole | Tinidazole Dapagliflozin may increase the excretion rate of Tinidazole which could result in a lower serum level and potentially a reduction in efficacy. |
Trospium | Trospium The metabolism of Dapagliflozin can be decreased when combined with Trospium. |
Bosentan | Bosentan The metabolism of Dapagliflozin can be increased when combined with Bosentan. |
Cefditoren | Cefditoren Dapagliflozin may increase the excretion rate of Cefdinir which could result in a lower serum level and potentially a reduction in efficacy. |
Cinacalcet | Cinacalcet The metabolism of Dapagliflozin can be decreased when combined with Cinacalcet. |
Cyanocobalamin Injection | Cyanocobalamin Injection Dapagliflozin may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy. |
Erlotinib | Erlotinib The metabolism of Erlotinib can be decreased when combined with Dapagliflozin. |
Eszopiclone | Eszopiclone Dapagliflozin may increase the excretion rate of Eszopiclone which could result in a lower serum level and potentially a reduction in efficacy. |
Ganciclovir | Ganciclovir Dapagliflozin may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy. |
Insulin Aspart (rDNA Origin) Injection | Insulin Aspart (rDNA Origin) Injection Dapagliflozin may increase the hypoglycemic activities of Insulin aspart. |
Ribavirin | Ribavirin Dapagliflozin may increase the excretion rate of Ribavirin which could result in a lower serum level and potentially a reduction in efficacy. |
Solifenacin | Solifenacin The metabolism of Dapagliflozin can be decreased when combined with Solifenacin. |
Valganciclovir | Valganciclovir Dapagliflozin may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy. |
Voriconazole | Voriconazole The metabolism of Dapagliflozin can be decreased when combined with Voriconazole. |
Dextroamphetamine | Dextroamphetamine Amphetamine may increase the orthostatic hypotensive activities of Dapagliflozin. |
Entecavir | Entecavir The metabolism of Entecavir can be decreased when combined with Dapagliflozin. |
Peginterferon Alfa-2a Injection | Peginterferon Alfa-2a Injection The metabolism of Dapagliflozin can be decreased when combined with Peginterferon alfa-2a. |
Peginterferon Alfa-2b (PEG-Intron) | Peginterferon Alfa-2b (PEG-Intron) The serum concentration of Dapagliflozin can be increased when it is combined with Peginterferon alfa-2b. |
Pramlintide Injection | Pramlintide Injection Dapagliflozin may increase the hypoglycemic activities of Pramlintide. |
Exenatide Injection | Exenatide Injection Dapagliflozin may increase the hypoglycemic activities of Exenatide. |
Isocarboxazid | Isocarboxazid Isocarboxazid may increase the orthostatic hypotensive activities of Dapagliflozin. |
Ramelteon | Ramelteon The metabolism of Ramelteon can be decreased when combined with Dapagliflozin. |
Darifenacin | Darifenacin The metabolism of Darifenacin can be decreased when combined with Dapagliflozin. |
Fentanyl | Fentanyl Dapagliflozin may increase the excretion rate of Fentanyl which could result in a lower serum level and potentially a reduction in efficacy. |
Pregabalin | Pregabalin The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Dapagliflozin. |
Deferasirox | Deferasirox The serum concentration of Dapagliflozin can be increased when it is combined with Deferasirox. |
Phenylephrine | Phenylephrine The metabolism of Dapagliflozin can be increased when combined with Phenylephrine. |
Tipranavir | Tipranavir The metabolism of Tipranavir can be decreased when combined with Dapagliflozin. |
Felbamate | Felbamate The metabolism of Dapagliflozin can be decreased when combined with Felbamate. |
Insulin Detemir (rDNA Origin) Injection | Insulin Detemir (rDNA Origin) Injection Dapagliflozin may increase the hypoglycemic activities of Insulin detemir. |
Ranolazine | Ranolazine The serum concentration of Dapagliflozin can be increased when it is combined with Ranolazine. |
Abatacept Injection | Abatacept Injection The metabolism of Dapagliflozin can be increased when combined with Abatacept. |
Rasagiline | Rasagiline Rasagiline may increase the orthostatic hypotensive activities of Dapagliflozin. |
Imatinib | Imatinib The metabolism of Dapagliflozin can be decreased when combined with Imatinib. |
Sitagliptin | Sitagliptin Dapagliflozin may increase the hypoglycemic activities of Sitagliptin. |
Varenicline | Varenicline Dapagliflozin may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy. |
Gefitinib | Gefitinib The metabolism of Dapagliflozin can be decreased when combined with Gefitinib. |
Albuterol | Albuterol Dapagliflozin may increase the excretion rate of Salbutamol which could result in a lower serum level and potentially a reduction in efficacy. |
Paliperidone | Paliperidone The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Paliperidone. |
Bortezomib | Bortezomib The metabolism of Bortezomib can be decreased when combined with Dapagliflozin. |
Clofarabine Injection | Clofarabine Injection Clofarabine may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Insulin Glulisine (rDNA origin) Injection | Insulin Glulisine (rDNA origin) Injection Dapagliflozin may increase the hypoglycemic activities of Insulin glulisine. |
Lubiprostone | Lubiprostone The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Lubiprostone. |
Primaquine | Primaquine The metabolism of Dapagliflozin can be decreased when combined with Primaquine. |
Aliskiren | Aliskiren The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Aliskiren. |
Bismuth Subsalicylate | Bismuth Subsalicylate Bismuth subsalicylate may increase the hypoglycemic activities of Dapagliflozin. |
Darunavir | Darunavir The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Darunavir. |
Pemetrexed Injection | Pemetrexed Injection The metabolism of Pemetrexed can be decreased when combined with Dapagliflozin. |
Lisdexamfetamine | Lisdexamfetamine The metabolism of Dapagliflozin can be decreased when combined with Lisdexamfetamine. |
Nabilone | Nabilone The metabolism of Dapagliflozin can be decreased when combined with Nabilone. |
Vorinostat | Vorinostat The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Vorinostat. |
Sorafenib | Sorafenib The metabolism of Dapagliflozin can be decreased when combined with Sorafenib. |
Sunitinib | Sunitinib Dapagliflozin may increase the hypoglycemic activities of Sunitinib. |
Dronabinol | Dronabinol The metabolism of Dapagliflozin can be decreased when combined with Dronabinol. |
Levocetirizine | Levocetirizine Dapagliflozin may increase the excretion rate of Levocetirizine which could result in a lower serum level and potentially a reduction in efficacy. |
Pegaptanib Injection | Pegaptanib Injection Dapagliflozin may increase the excretion rate of Pegaptanib which could result in a lower serum level and potentially a reduction in efficacy. |
Dasatinib | Dasatinib The metabolism of Dasatinib can be decreased when combined with Dapagliflozin. |
Mexiletine | Mexiletine The metabolism of Mexiletine can be decreased when combined with Dapagliflozin. |
Armodafinil | Armodafinil The metabolism of Dapagliflozin can be decreased when combined with Armodafinil. |
Azacitidine Injection | Azacitidine Injection Dapagliflozin may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy. |
Paclitaxel (with polyoxyethylated castor oil) Injection | Paclitaxel (with polyoxyethylated castor oil) Injection The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Castor oil. |
Temsirolimus | Temsirolimus The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Temsirolimus. |
Lenalidomide | Lenalidomide Dapagliflozin may increase the excretion rate of Lenalidomide which could result in a lower serum level and potentially a reduction in efficacy. |
Nilotinib | Nilotinib The metabolism of Dapagliflozin can be decreased when combined with Nilotinib. |
Bexarotene | Bexarotene The metabolism of Dapagliflozin can be decreased when combined with Bexarotene. |
Budesonide | Budesonide The risk or severity of hyperglycemia can be increased when Budesonide is combined with Dapagliflozin. |
Desmopressin | Desmopressin Dapagliflozin may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy. |
Doripenem Injection | Doripenem Injection Dapagliflozin may increase the excretion rate of Doripenem which could result in a lower serum level and potentially a reduction in efficacy. |
Etravirine | Etravirine The metabolism of Dapagliflozin can be decreased when combined with Etravirine. |
Arsenic Trioxide Injection | Arsenic Trioxide Injection The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Arsenic trioxide. |
Desvenlafaxine | Desvenlafaxine The risk or severity of hypoglycemia can be increased when Desvenlafaxine is combined with Dapagliflozin. |
Cevimeline | Cevimeline Dapagliflozin may increase the excretion rate of Cevimeline which could result in a lower serum level and potentially a reduction in efficacy. |
Nebivolol | Nebivolol The therapeutic efficacy of Nebivolol can be increased when used in combination with Dapagliflozin. |
Tretinoin | Tretinoin The metabolism of Dapagliflozin can be decreased when combined with Tretinoin. |
Bendamustine Injection | Bendamustine Injection The metabolism of Bendamustine can be decreased when combined with Dapagliflozin. |
Pilocarpine | Pilocarpine The metabolism of Dapagliflozin can be decreased when combined with Pilocarpine. |
Flecainide | Flecainide The metabolism of Flecainide can be decreased when combined with Dapagliflozin. |
Certolizumab Injection | Certolizumab Injection The metabolism of Dapagliflozin can be increased when combined with Certolizumab pegol. |
Daptomycin Injection | Daptomycin Injection Dapagliflozin may increase the excretion rate of Daptomycin which could result in a lower serum level and potentially a reduction in efficacy. |
Praziquantel | Praziquantel The metabolism of Praziquantel can be decreased when combined with Dapagliflozin. |
Methylnaltrexone Injection | Methylnaltrexone Injection Dapagliflozin may increase the excretion rate of Methylnaltrexone which could result in a lower serum level and potentially a reduction in efficacy. |
Midazolam | Midazolam Dapagliflozin may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy. |
Naltrexone Injection | Naltrexone Injection The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Naltrexone. |
Dexrazoxane Injection | Dexrazoxane Injection Dapagliflozin may increase the excretion rate of Dexrazoxane which could result in a lower serum level and potentially a reduction in efficacy. |
Eltrombopag | Eltrombopag The metabolism of Dapagliflozin can be decreased when combined with Eltrombopag. |
Milnacipran | Milnacipran The risk or severity of hypoglycemia can be increased when Milnacipran is combined with Dapagliflozin. |
Plerixafor Injection | Plerixafor Injection Dapagliflozin may increase the excretion rate of Plerixafor which could result in a lower serum level and potentially a reduction in efficacy. |
Sodium Phosphate | Sodium Phosphate Dapagliflozin may increase the nephrotoxic activities of Sodium phosphate, monobasic. |
Fesoterodine | Fesoterodine Dapagliflozin may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy. |
Betaxolol | Betaxolol The therapeutic efficacy of Betaxolol can be increased when used in combination with Dapagliflozin. |
Iloperidone | Iloperidone The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Iloperidone. |
Prasugrel | Prasugrel Prasugrel may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Lacosamide | Lacosamide The metabolism of Dapagliflozin can be decreased when combined with Lacosamide. |
Everolimus | Everolimus The metabolism of Everolimus can be decreased when combined with Dapagliflozin. |
Dronedarone | Dronedarone The metabolism of Dronedarone can be decreased when combined with Dapagliflozin. |
Pralatrexate Injection | Pralatrexate Injection Dapagliflozin may increase the excretion rate of Pralatrexate which could result in a lower serum level and potentially a reduction in efficacy. |
Palonosetron Injection | Palonosetron Injection Dapagliflozin may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy. |
Telavancin Injection | Telavancin Injection Dapagliflozin may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy. |
Tapentadol | Tapentadol The metabolism of Dapagliflozin can be decreased when combined with Tapentadol. |
Topotecan | Topotecan Dapagliflozin may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy. |
Golimumab Injection | Golimumab Injection The metabolism of Dapagliflozin can be increased when combined with Golimumab. |
Pazopanib | Pazopanib The metabolism of Pazopanib can be decreased when combined with Dapagliflozin. |
Asenapine | Asenapine The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Asenapine. |
Pitavastatin | Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Dapagliflozin. |
Albendazole | Albendazole The metabolism of Albendazole can be decreased when combined with Dapagliflozin. |
Levonorgestrel | Levonorgestrel The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Levonorgestrel. |
Oxymorphone | Oxymorphone The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Oxymorphone. |
Liraglutide Injection | Liraglutide Injection Dapagliflozin may increase the hypoglycemic activities of Liraglutide. |
Tocilizumab Injection | Tocilizumab Injection The metabolism of Dapagliflozin can be increased when combined with Tocilizumab. |
Dalfampridine | Dalfampridine Dapagliflozin may increase the excretion rate of Dalfampridine which could result in a lower serum level and potentially a reduction in efficacy. |
Lurasidone | Lurasidone The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Lurasidone. |
Acetaminophen Injection | Acetaminophen Injection The metabolism of Acetaminophen can be decreased when combined with Dapagliflozin. |
Vilazodone | Vilazodone The metabolism of Dapagliflozin can be decreased when combined with Vilazodone. |
Ipilimumab Injection | Ipilimumab Injection Dapagliflozin may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy. |
Denileukin Diftitox Injection | Denileukin Diftitox Injection Dapagliflozin may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy. |
Terbutaline Injection | Terbutaline Injection Dapagliflozin may increase the excretion rate of Terbutaline which could result in a lower serum level and potentially a reduction in efficacy. |
Azilsartan | Azilsartan The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Azilsartan medoxomil. |
Roflumilast | Roflumilast Dapagliflozin may increase the excretion rate of Roflumilast which could result in a lower serum level and potentially a reduction in efficacy. |
Linagliptin | Linagliptin Dapagliflozin may increase the hypoglycemic activities of Linagliptin. |
Rilpivirine | Rilpivirine The metabolism of Rilpivirine can be decreased when combined with Dapagliflozin. |
Cyclophosphamide Injection | Cyclophosphamide Injection The metabolism of Dapagliflozin can be decreased when combined with Cyclophosphamide. |
Abiraterone | Abiraterone The serum concentration of Dapagliflozin can be increased when it is combined with Abiraterone. |
Triptorelin Injection | Triptorelin Injection The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Triptorelin. |
Rivaroxaban | Rivaroxaban Dapagliflozin may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy. |
Ticagrelor | Ticagrelor The metabolism of Dapagliflozin can be decreased when combined with Ticagrelor. |
Ruxolitinib | Ruxolitinib Dapagliflozin may increase the excretion rate of Ruxolitinib which could result in a lower serum level and potentially a reduction in efficacy. |
Clobazam | Clobazam The metabolism of Dapagliflozin can be decreased when combined with Clobazam. |
Vemurafenib | Vemurafenib The serum concentration of Dapagliflozin can be increased when it is combined with Vemurafenib. |
Vismodegib | Vismodegib The metabolism of Dapagliflozin can be decreased when combined with Vismodegib. |
Deferiprone | Deferiprone Dapagliflozin may increase the excretion rate of Deferiprone which could result in a lower serum level and potentially a reduction in efficacy. |
Axitinib | Axitinib The metabolism of Axitinib can be decreased when combined with Dapagliflozin. |
Naloxone Injection | Naloxone Injection Dapagliflozin may increase the excretion rate of Naloxone which could result in a lower serum level and potentially a reduction in efficacy. |
Ambrisentan | Ambrisentan Dapagliflozin may increase the hypotensive activities of Ambrisentan. |
Fondaparinux Injection | Fondaparinux Injection Dapagliflozin may increase the excretion rate of Fondaparinux which could result in a lower serum level and potentially a reduction in efficacy. |
Iloprost | Iloprost The risk or severity of adverse effects can be increased when Iloprost is combined with Dapagliflozin. |
Enzalutamide | Enzalutamide The metabolism of Dapagliflozin can be increased when combined with Enzalutamide. |
Mirabegron | Mirabegron The metabolism of Dapagliflozin can be decreased when combined with Mirabegron. |
Regorafenib | Regorafenib The metabolism of Dapagliflozin can be decreased when combined with Regorafenib. |
Corticotropin, Repository Injection | Corticotropin, Repository Injection The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Dapagliflozin. |
Linaclotide | Linaclotide The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Linaclotide. |
Teriflunomide | Teriflunomide The serum concentration of Dapagliflozin can be decreased when it is combined with Teriflunomide. |
Lorcaserin | Lorcaserin Dapagliflozin may increase the hypoglycemic activities of Mecasermin. |
Cabozantinib (thyroid cancer) | Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Dapagliflozin. |
Teduglutide Injection | Teduglutide Injection Dapagliflozin may increase the excretion rate of Teduglutide which could result in a lower serum level and potentially a reduction in efficacy. |
Alogliptin | Alogliptin Dapagliflozin may increase the hypoglycemic activities of Alogliptin. |
Ponatinib | Ponatinib The metabolism of Ponatinib can be decreased when combined with Dapagliflozin. |
Pomalidomide | Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Dapagliflozin. |
Apixaban | Apixaban The metabolism of Apixaban can be decreased when combined with Dapagliflozin. |
Canagliflozin | Canagliflozin Dapagliflozin may increase the hypoglycemic activities of Canagliflozin. |
Methazolamide | Methazolamide The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Methazolamide. |
Dabrafenib | Dabrafenib The metabolism of Dapagliflozin can be increased when combined with Dabrafenib. |
Ospemifene | Ospemifene The metabolism of Dapagliflozin can be decreased when combined with Ospemifene. |
Trametinib | Trametinib Dapagliflozin may increase the excretion rate of Trametinib which could result in a lower serum level and potentially a reduction in efficacy. |
Levomilnacipran | Levomilnacipran The risk or severity of hypoglycemia can be increased when Dapagliflozin is combined with Levomilnacipran. |
Ertapenem Injection | Ertapenem Injection Dapagliflozin may increase the excretion rate of Ertapenem which could result in a lower serum level and potentially a reduction in efficacy. |
Vortioxetine | Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Dapagliflozin. |
Perampanel | Perampanel The metabolism of Perampanel can be decreased when combined with Dapagliflozin. |
Ibrutinib | Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Dapagliflozin. |
Avanafil | Avanafil The risk or severity of hypotension can be increased when Avanafil is combined with Dapagliflozin. |
Ketorolac Injection | Ketorolac Injection The metabolism of Dapagliflozin can be decreased when combined with Ketorolac. |
Obinutuzumab Injection | Obinutuzumab Injection The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Obinutuzumab. |
Simeprevir | Simeprevir The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Simeprevir. |
Sofosbuvir | Sofosbuvir Dapagliflozin may increase the excretion rate of Sofosbuvir which could result in a lower serum level and potentially a reduction in efficacy. |
Apremilast | Apremilast The metabolism of Dapagliflozin can be increased when combined with Apremilast. |
Droxidopa | Droxidopa The risk or severity of Cardiac Arrhythmia can be increased when Droxidopa is combined with Dapagliflozin. |
Ceritinib | Ceritinib The metabolism of Dapagliflozin can be decreased when combined with Ceritinib. |
Siltuximab Injection | Siltuximab Injection The metabolism of Dapagliflozin can be increased when combined with Siltuximab. |
Albiglutide Injection | Albiglutide Injection Dapagliflozin may increase the hypoglycemic activities of Albiglutide. |
Belinostat Injection | Belinostat Injection The metabolism of Dapagliflozin can be increased when combined with Belinostat. |
Testosterone Injection | Testosterone Injection Testosterone may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Oritavancin Injection | Oritavancin Injection The metabolism of Dapagliflozin can be decreased when combined with Oritavancin. |
Empagliflozin | Empagliflozin Dapagliflozin may increase the diuretic activities of Empagliflozin. |
Hydrocodone | Hydrocodone The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Hydrocodone. |
Dulaglutide Injection | Dulaglutide Injection Dapagliflozin may increase the hypoglycemic activities of Dulaglutide. |
Edoxaban | Edoxaban Dapagliflozin may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy. |
Peginterferon Beta-1a Injection | Peginterferon Beta-1a Injection The metabolism of Dapagliflozin can be decreased when combined with Peginterferon beta-1a. |
Methamphetamine | Methamphetamine Metamfetamine may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Tasimelteon | Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Dapagliflozin. |
Riociguat | Riociguat The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Riociguat. |
Lanreotide Injection | Lanreotide Injection The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Lanreotide. |
Pirfenidone | Pirfenidone The metabolism of Dapagliflozin can be decreased when combined with Pirfenidone. |
Secukinumab Injection | Secukinumab Injection The metabolism of Dapagliflozin can be increased when combined with Secukinumab. |
Risperidone Injection | Risperidone Injection Dapagliflozin may increase the hypotensive activities of Risperidone. |
Insulin Human Inhalation | Insulin Human Inhalation Dapagliflozin may increase the hypoglycemic activities of Insulin human. |
Lenvatinib | Lenvatinib The metabolism of Dapagliflozin can be decreased when combined with Lenvatinib. |
Naloxegol | Naloxegol The metabolism of Dapagliflozin can be decreased when combined with Naloxegol. |
Panobinostat | Panobinostat The metabolism of Dapagliflozin can be decreased when combined with Panobinostat. |
Dinutuximab Injection | Dinutuximab Injection The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Dinutuximab. |
Haloperidol Injection | Haloperidol Injection The serum concentration of Haloperidol can be increased when it is combined with Dapagliflozin. |
Amiloride | Amiloride The risk or severity of adverse effects can be increased when Amiloride is combined with Dapagliflozin. |
Macitentan | Macitentan Dapagliflozin may increase the excretion rate of Macitentan which could result in a lower serum level and potentially a reduction in efficacy. |
Rolapitant | Rolapitant The metabolism of Dapagliflozin can be decreased when combined with Rolapitant. |
Prednisolone | Prednisolone The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Dapagliflozin. |
Brexpiprazole | Brexpiprazole The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Brexpiprazole. |
Ziprasidone Injection | Ziprasidone Injection The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Ziprasidone. |
Cariprazine | Cariprazine The metabolism of Dapagliflozin can be decreased when combined with Cariprazine. |
Penicillin G Procaine Injection | Penicillin G Procaine Injection Dapagliflozin may increase the excretion rate of Procaine benzylpenicillin which could result in a lower serum level and potentially a reduction in efficacy. |
Eluxadoline | Eluxadoline The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Eluxadoline. |
Insulin Degludec (rDNA Origin) Injection | Insulin Degludec (rDNA Origin) Injection Dapagliflozin may increase the hypoglycemic activities of Insulin degludec. |
Trabectedin Injection | Trabectedin Injection The metabolism of Dapagliflozin can be decreased when combined with Trabectedin. |
Osimertinib | Osimertinib The serum concentration of Dapagliflozin can be decreased when it is combined with Osimertinib. |
Ixazomib | Ixazomib Dapagliflozin may increase the excretion rate of Ixazomib which could result in a lower serum level and potentially a reduction in efficacy. |
Lesinurad | Lesinurad Dapagliflozin may increase the excretion rate of Lesinurad which could result in a lower serum level and potentially a reduction in efficacy. |
Amphotericin B Liposomal Injection | Amphotericin B Liposomal Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Dapagliflozin. |
Dexamethasone Injection | Dexamethasone Injection The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Dapagliflozin. |
Brivaracetam Injection | Brivaracetam Injection Brivaracetam may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Cobicistat | Cobicistat The metabolism of Dapagliflozin can be decreased when combined with Cobicistat. |
Selexipag | Selexipag Dapagliflozin may increase the hypotensive activities of Selexipag. |
Obeticholic Acid | Obeticholic Acid The metabolism of Dapagliflozin can be decreased when combined with Obeticholic acid. |
Diphenhydramine Injection | Diphenhydramine Injection The metabolism of Dapagliflozin can be decreased when combined with Diphenhydramine. |
Furosemide Injection | Furosemide Injection The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Furosemide. |
Rucaparib | Rucaparib The metabolism of Dapagliflozin can be decreased when combined with Rucaparib. |
Lixisenatide Injection | Lixisenatide Injection Dapagliflozin may increase the hypoglycemic activities of Lixisenatide. |
Doxepin (Insomnia) | Doxepin (Insomnia) The metabolism of Dapagliflozin can be decreased when combined with Doxepin. |
Plecanatide | Plecanatide The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Plecanatide. |
Deutetrabenazine | Deutetrabenazine Dapagliflozin may increase the excretion rate of Deutetrabenazine which could result in a lower serum level and potentially a reduction in efficacy. |
Valbenazine | Valbenazine Dapagliflozin may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy. |
Deflazacort | Deflazacort The risk or severity of hyperglycemia can be increased when Deflazacort is combined with Dapagliflozin. |
Safinamide | Safinamide Safinamide may increase the orthostatic hypotensive activities of Dapagliflozin. |
Naldemedine | Naldemedine Dapagliflozin may increase the excretion rate of Naldemedine which could result in a lower serum level and potentially a reduction in efficacy. |
Midostaurin | Midostaurin The metabolism of Dapagliflozin can be decreased when combined with Midostaurin. |
Enasidenib | Enasidenib The metabolism of Dapagliflozin can be decreased when combined with Enasidenib. |
Benznidazole | Benznidazole Dapagliflozin may increase the excretion rate of Benznidazole which could result in a lower serum level and potentially a reduction in efficacy. |
Delafloxacin | Delafloxacin The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Delafloxacin. |
Letermovir | Letermovir The metabolism of Letermovir can be decreased when combined with Dapagliflozin. |
Semaglutide Injection | Semaglutide Injection Dapagliflozin may increase the hypoglycemic activities of Semaglutide. |
Tetrabenazine | Tetrabenazine The metabolism of Dapagliflozin can be decreased when combined with Tetrabenazine. |
Ertugliflozin | Ertugliflozin The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Ertugliflozin. |
Buprenorphine Injection | Buprenorphine Injection The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Buprenorphine. |
Apalutamide | Apalutamide Apalutamide may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Fostamatinib | Fostamatinib The risk or severity of hypotension can be increased when Fostamatinib is combined with Dapagliflozin. |
Avatrombopag | Avatrombopag The metabolism of Dapagliflozin can be increased when combined with Avatrombopag. |
Baricitinib | Baricitinib Dapagliflozin may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy. |
Lofexidine | Lofexidine The metabolism of Lofexidine can be decreased when combined with Dapagliflozin. |
Plazomicin Injection | Plazomicin Injection Dapagliflozin may increase the excretion rate of Plazomicin which could result in a lower serum level and potentially a reduction in efficacy. |
Eliglustat | Eliglustat The metabolism of Dapagliflozin can be decreased when combined with Eliglustat. |
Encorafenib | Encorafenib The metabolism of Encorafenib can be decreased when combined with Dapagliflozin. |
Binimetinib | Binimetinib The metabolism of Binimetinib can be decreased when combined with Dapagliflozin. |
Elagolix | Elagolix The metabolism of Elagolix can be decreased when combined with Dapagliflozin. |
Tafenoquine | Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Dapagliflozin. |
Cannabidiol | Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Dapagliflozin. |
Dacomitinib | Dacomitinib The metabolism of Dapagliflozin can be decreased when combined with Dacomitinib. |
Stiripentol | Stiripentol The metabolism of Dapagliflozin can be decreased when combined with Stiripentol. |
Paclitaxel (with albumin) Injection | Paclitaxel (with albumin) Injection The risk or severity of adverse effects can be increased when Paclitaxel is combined with Dapagliflozin. |
Rifamycin | Rifamycin The metabolism of Dapagliflozin can be decreased when combined with Rifamycin. |
Prucalopride | Prucalopride The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Prucalopride. |
Magnesium Citrate | Magnesium Citrate The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Magnesium citrate. |
Emapalumab-lzsg Injection | Emapalumab-lzsg Injection The metabolism of Dapagliflozin can be increased when combined with Emapalumab. |
Siponimod | Siponimod The metabolism of Siponimod can be decreased when combined with Dapagliflozin. |
Acyclovir Ophthalmic | Acyclovir Ophthalmic The metabolism of Acyclovir can be decreased when combined with Dapagliflozin. |
Erdafitinib | Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Dapagliflozin. |
Alpelisib | Alpelisib The serum concentration of Dapagliflozin can be decreased when it is combined with Alpelisib. |
Solriamfetol | Solriamfetol Dapagliflozin may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy. |
Triclabendazole | Triclabendazole The metabolism of Dapagliflozin can be decreased when combined with Triclabendazole. |
Istradefylline | Istradefylline The metabolism of Istradefylline can be decreased when combined with Dapagliflozin. |
Pitolisant | Pitolisant The serum concentration of Dapagliflozin can be decreased when it is combined with Pitolisant. |
Fedratinib | Fedratinib The metabolism of Dapagliflozin can be decreased when combined with Fedratinib. |
Phenytoin Injection | Phenytoin Injection The metabolism of Dapagliflozin can be decreased when combined with Phenytoin. |
Fosphenytoin Injection | Fosphenytoin Injection The metabolism of Dapagliflozin can be decreased when combined with Fosphenytoin. |
Voxelotor | Voxelotor The metabolism of Voxelotor can be decreased when combined with Dapagliflozin. |
Avapritinib | Avapritinib The metabolism of Avapritinib can be decreased when combined with Dapagliflozin. |
Cenobamate | Cenobamate The serum concentration of Dapagliflozin can be decreased when it is combined with Cenobamate. |
Teprotumumab-trbw Injection | Teprotumumab-trbw Injection The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Teprotumumab. |
Selumetinib | Selumetinib The metabolism of Selumetinib can be decreased when combined with Dapagliflozin. |
Tucatinib | Tucatinib The metabolism of Tucatinib can be decreased when combined with Dapagliflozin. |
Capmatinib | Capmatinib The metabolism of Dapagliflozin can be decreased when combined with Capmatinib. |
Fenfluramine | Fenfluramine The metabolism of Dapagliflozin can be decreased when combined with Fenfluramine. |
Octreotide | Octreotide The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Octreotide. |
Pralsetinib | Pralsetinib The metabolism of Dapagliflozin can be decreased when combined with Pralsetinib. |
Satralizumab-mwge Injection | Satralizumab-mwge Injection The serum concentration of Dapagliflozin can be decreased when it is combined with Satralizumab. |
Progestin-Only (drospirenone) Oral Contraceptives | Progestin-Only (drospirenone) Oral Contraceptives The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Drospirenone. |
Viloxazine | Viloxazine Dapagliflozin may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy. |
Theophylline | Theophylline The metabolism of Theophylline can be decreased when combined with Dapagliflozin. |
Indomethacin | Indomethacin The metabolism of Dapagliflozin can be decreased when combined with Indomethacin. |
Mefenamic Acid | Mefenamic Acid The metabolism of Dapagliflozin can be decreased when combined with Mefenamic acid. |
Naproxen | Naproxen The metabolism of Naproxen can be decreased when combined with Dapagliflozin. |
Trazodone | Trazodone The metabolism of Dapagliflozin can be decreased when combined with Trazodone. |
Isotretinoin | Isotretinoin Dapagliflozin may increase the excretion rate of Isotretinoin which could result in a lower serum level and potentially a reduction in efficacy. |
Sucralfate | Sucralfate Dapagliflozin may increase the excretion rate of Sucralfate which could result in a lower serum level and potentially a reduction in efficacy. |
Hydroxyurea | Hydroxyurea The metabolism of Dapagliflozin can be decreased when combined with Hydroxyurea. |
Floxuridine | Floxuridine The metabolism of Dapagliflozin can be decreased when combined with Floxuridine. |
Phenobarbital | Phenobarbital The metabolism of Dapagliflozin can be decreased when combined with Phenobarbital. |
Metaxalone | Metaxalone Dapagliflozin may increase the excretion rate of Metaxalone which could result in a lower serum level and potentially a reduction in efficacy. |
Methotrexate Injection | Methotrexate Injection Dapagliflozin may increase the excretion rate of Methotrexate which could result in a lower serum level and potentially a reduction in efficacy. |
Levorphanol | Levorphanol The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Levorphanol. |
Primidone | Primidone The metabolism of Dapagliflozin can be increased when combined with Primidone. |
Methsuximide | Methsuximide The risk or severity of hypoglycemia can be increased when Methsuximide is combined with Dapagliflozin. |
Chlorpromazine | Chlorpromazine The metabolism of Chlorpromazine can be decreased when combined with Dapagliflozin. |
Diazepam | Diazepam Diazepam may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Oxazepam | Oxazepam Dapagliflozin may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy. |
Flurazepam | Flurazepam Dapagliflozin may increase the excretion rate of Flurazepam which could result in a lower serum level and potentially a reduction in efficacy. |
Clorazepate | Clorazepate Dapagliflozin may increase the excretion rate of Clorazepic acid which could result in a lower serum level and potentially a reduction in efficacy. |
Lorazepam | Lorazepam Dapagliflozin may increase the excretion rate of Lorazepam which could result in a lower serum level and potentially a reduction in efficacy. |
Phenoxybenzamine | Phenoxybenzamine The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Phenoxybenzamine. |
Carmustine | Carmustine The metabolism of Carmustine can be decreased when combined with Dapagliflozin. |
Amantadine | Amantadine Dapagliflozin may increase the excretion rate of Amantadine which could result in a lower serum level and potentially a reduction in efficacy. |
Codeine | Codeine The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Codeine. |
Bromocriptine | Bromocriptine Dapagliflozin may increase the hypoglycemic activities of Bromocriptine. |
Tranylcypromine | Tranylcypromine The metabolism of Dapagliflozin can be decreased when combined with Tranylcypromine. |
Phenelzine | Phenelzine Phenelzine may increase the orthostatic hypotensive activities of Dapagliflozin. |
Procarbazine | Procarbazine Procarbazine may increase the orthostatic hypotensive activities of Dapagliflozin. |
Tetracycline | Tetracycline Dapagliflozin may increase the excretion rate of Tetracycline which could result in a lower serum level and potentially a reduction in efficacy. |
Prochlorperazine | Prochlorperazine The metabolism of Dapagliflozin can be decreased when combined with Prochlorperazine. |
Thioridazine | Thioridazine The metabolism of Dapagliflozin can be decreased when combined with Thioridazine. |
Trifluoperazine | Trifluoperazine The metabolism of Trifluoperazine can be decreased when combined with Dapagliflozin. |
Bleomycin | Bleomycin Dapagliflozin may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy. |
Dapsone | Dapsone The metabolism of Dapagliflozin can be decreased when combined with Dapsone. |
Sulfadiazine | Sulfadiazine The metabolism of Dapagliflozin can be decreased when combined with Sulfadiazine. |
Oxycodone | Oxycodone The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Oxycodone. |
Methadone | Methadone The metabolism of Dapagliflozin can be decreased when combined with Methadone. |
Oxybutynin | Oxybutynin The metabolism of Dapagliflozin can be decreased when combined with Oxybutynin. |
Benztropine | Benztropine Benzatropine may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Maprotiline | Maprotiline The metabolism of Maprotiline can be decreased when combined with Dapagliflozin. |
Ibuprofen | Ibuprofen Ibuprofen may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Orphenadrine | Orphenadrine The metabolism of Dapagliflozin can be decreased when combined with Orphenadrine. |
Perphenazine | Perphenazine The metabolism of Perphenazine can be decreased when combined with Dapagliflozin. |
Azathioprine | Azathioprine The metabolism of Azathioprine can be decreased when combined with Dapagliflozin. |
Fluphenazine | Fluphenazine The metabolism of Dapagliflozin can be decreased when combined with Fluphenazine. |
Phentermine | Phentermine The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Phentermine. |
Methylphenidate | Methylphenidate Dapagliflozin may increase the excretion rate of Methylphenidate which could result in a lower serum level and potentially a reduction in efficacy. |
Amoxapine | Amoxapine The metabolism of Dapagliflozin can be decreased when combined with Amoxapine. |
Sulfasalazine | Sulfasalazine Sulfasalazine may increase the hypoglycemic activities of Dapagliflozin. |
Hydrocortisone | Hydrocortisone The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Dapagliflozin. |
Doxorubicin | Doxorubicin The metabolism of Dapagliflozin can be decreased when combined with Doxorubicin. |
Phenazopyridine | Phenazopyridine Dapagliflozin may increase the excretion rate of Phenazopyridine which could result in a lower serum level and potentially a reduction in efficacy. |
Carbamazepine | Carbamazepine The metabolism of Dapagliflozin can be increased when combined with Carbamazepine. |
Methyldopa | Methyldopa Dapagliflozin may increase the excretion rate of Methyldopa which could result in a lower serum level and potentially a reduction in efficacy. |
Clonidine | Clonidine The metabolism of Clonidine can be decreased when combined with Dapagliflozin. |
Prazosin | Prazosin The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Prazosin. |
Hydralazine | Hydralazine Dapagliflozin may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy. |
Cimetidine | Cimetidine The metabolism of Dapagliflozin can be decreased when combined with Cimetidine. |
Warfarin | Warfarin The metabolism of Warfarin can be decreased when combined with Dapagliflozin. |
Clonazepam | Clonazepam Dapagliflozin may increase the excretion rate of Clonazepam which could result in a lower serum level and potentially a reduction in efficacy. |
Loperamide | Loperamide The risk or severity of hypoglycemia can be increased when Loperamide is combined with Dapagliflozin. |
Promethazine | Promethazine The metabolism of Dapagliflozin can be decreased when combined with Promethazine. |
Meclofenamate | Meclofenamate Dapagliflozin may increase the excretion rate of Meclofenamic acid which could result in a lower serum level and potentially a reduction in efficacy. |
Nitrofurantoin | Nitrofurantoin Dapagliflozin may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy. |
Griseofulvin | Griseofulvin The metabolism of Dapagliflozin can be increased when combined with Griseofulvin. |
Digoxin | Digoxin Dapagliflozin may increase the excretion rate of Digoxin which could result in a lower serum level and potentially a reduction in efficacy. |
Chloroquine | Chloroquine The metabolism of Dapagliflozin can be decreased when combined with Chloroquine. |
Quinine | Quinine The metabolism of Dapagliflozin can be decreased when combined with Quinine. |
Ethosuximide | Ethosuximide The risk or severity of hypoglycemia can be increased when Ethosuximide is combined with Dapagliflozin. |
Triamterene | Triamterene The metabolism of Triamterene can be decreased when combined with Dapagliflozin. |
Lactulose | Lactulose The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Lactulose. |
Sulfinpyrazone | Sulfinpyrazone The metabolism of Dapagliflozin can be decreased when combined with Sulfinpyrazone. |
Chlorothiazide | Chlorothiazide The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Chlorothiazide. |
Chlorthalidone | Chlorthalidone The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Chlorthalidone. |
Metolazone | Metolazone The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Metolazone. |
Secobarbital | Secobarbital Secobarbital may increase the hypotensive activities of Dapagliflozin. |
Desipramine | Desipramine The metabolism of Desipramine can be decreased when combined with Dapagliflozin. |
Amitriptyline | Amitriptyline The metabolism of Dapagliflozin can be decreased when combined with Amitriptyline. |
Imipramine | Imipramine The metabolism of Imipramine can be decreased when combined with Dapagliflozin. |
Probenecid | Probenecid The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Probenecid. |
Quinidine | Quinidine The metabolism of Dapagliflozin can be decreased when combined with Quinidine. |
Procainamide | Procainamide The metabolism of Procainamide can be decreased when combined with Dapagliflozin. |
Isoniazid | Isoniazid The metabolism of Dapagliflozin can be decreased when combined with Isoniazid. |
Pyrazinamide | Pyrazinamide Dapagliflozin may increase the excretion rate of Pyrazinamide which could result in a lower serum level and potentially a reduction in efficacy. |
Rifampin | Rifampin The metabolism of Dapagliflozin can be increased when combined with Rifampicin. |
Disopyramide | Disopyramide Dapagliflozin may increase the hypoglycemic activities of Disopyramide. |
Valproic Acid | Valproic Acid The metabolism of Dapagliflozin can be decreased when combined with Valproic acid. |
Tamoxifen | Tamoxifen The metabolism of Dapagliflozin can be decreased when combined with Tamoxifen. |
Butabarbital | Butabarbital Dapagliflozin may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy. |
Levothyroxine | Levothyroxine The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Levothyroxine. |
Liothyronine | Liothyronine The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Liothyronine. |
Methimazole | Methimazole The metabolism of Dapagliflozin can be decreased when combined with Methimazole. |
Chlorpropamide | Chlorpropamide Dapagliflozin may increase the hypoglycemic activities of Chlorpropamide. |
Tolbutamide | Tolbutamide Dapagliflozin may increase the hypoglycemic activities of Tolbutamide. |
Tolazamide | Tolazamide Dapagliflozin may increase the hypoglycemic activities of Tolazamide. |
Dextromethorphan | Dextromethorphan The metabolism of Dapagliflozin can be decreased when combined with Dextromethorphan. |
Cyclobenzaprine | Cyclobenzaprine The metabolism of Cyclobenzaprine can be decreased when combined with Dapagliflozin. |
Niacin | Niacin The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Niacin. |
Baclofen | Baclofen The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Baclofen. |
Clemastine | Clemastine The metabolism of Dapagliflozin can be decreased when combined with Clemastine. |
Chlorpheniramine | Chlorpheniramine The metabolism of Dapagliflozin can be decreased when combined with Chlorpheniramine. |
Meclizine | Meclizine The metabolism of Dapagliflozin can be decreased when combined with Meclizine. |
Ethambutol | Ethambutol Dapagliflozin may increase the excretion rate of Ethambutol which could result in a lower serum level and potentially a reduction in efficacy. |
Methyclothiazide | Methyclothiazide The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Methyclothiazide. |
Hydrochlorothiazide | Hydrochlorothiazide The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Hydrochlorothiazide. |
Chlorzoxazone | Chlorzoxazone The metabolism of Chlorzoxazone can be decreased when combined with Dapagliflozin. |
Pyridoxine | Pyridoxine Dapagliflozin may increase the excretion rate of Pyridoxine which could result in a lower serum level and potentially a reduction in efficacy. |
Folic Acid | Folic Acid Dapagliflozin may increase the excretion rate of Folic acid which could result in a lower serum level and potentially a reduction in efficacy. |
Danazol | Danazol The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Danazol. |
Propranolol (Cardiovascular) | Propranolol (Cardiovascular) The therapeutic efficacy of Propranolol can be increased when used in combination with Dapagliflozin. |
Minoxidil | Minoxidil The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Minoxidil. |
Pseudoephedrine | Pseudoephedrine The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Pseudoephedrine. |
Nortriptyline | Nortriptyline The metabolism of Dapagliflozin can be decreased when combined with Nortriptyline. |
Spironolactone | Spironolactone The risk or severity of adverse effects can be increased when Spironolactone is combined with Dapagliflozin. |
Amphotericin B Injection | Amphotericin B Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Dapagliflozin. |
Phytonadione | Phytonadione Dapagliflozin may increase the excretion rate of Phylloquinone which could result in a lower serum level and potentially a reduction in efficacy. |
Nadolol | Nadolol The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Nadolol. |
Butorphanol Injection | Butorphanol Injection The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Butorphanol. |
Nalbuphine Injection | Nalbuphine Injection The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Nalbuphine. |
Allopurinol | Allopurinol Dapagliflozin may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy. |
Fluoxymesterone | Fluoxymesterone Fluoxymesterone may increase the hypoglycemic activities of Dapagliflozin. |
Flavoxate | Flavoxate Dapagliflozin may increase the excretion rate of Flavoxate which could result in a lower serum level and potentially a reduction in efficacy. |
Papaverine | Papaverine The risk or severity of adverse effects can be increased when Papaverine is combined with Dapagliflozin. |
Fluorouracil Injection | Fluorouracil Injection The metabolism of Fluorouracil can be decreased when combined with Dapagliflozin. |
Colchicine | Colchicine Dapagliflozin may increase the excretion rate of Colchicine which could result in a lower serum level and potentially a reduction in efficacy. |
Cefaclor | Cefaclor Dapagliflozin may increase the excretion rate of Cefaclor which could result in a lower serum level and potentially a reduction in efficacy. |
Cefadroxil | Cefadroxil Dapagliflozin may increase the excretion rate of Cefadroxil which could result in a lower serum level and potentially a reduction in efficacy. |
Cephalexin | Cephalexin Dapagliflozin may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy. |
Dacarbazine | Dacarbazine The metabolism of Dacarbazine can be decreased when combined with Dapagliflozin. |
Acetazolamide | Acetazolamide The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Acetazolamide. |
Calcitonin Salmon Injection | Calcitonin Salmon Injection Dapagliflozin may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy. |
Ketoconazole | Ketoconazole The metabolism of Dapagliflozin can be decreased when combined with Ketoconazole. |
Pyrantel | Pyrantel Dapagliflozin may increase the excretion rate of Pyrantel which could result in a lower serum level and potentially a reduction in efficacy. |
Captopril | Captopril The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Captopril is combined with Dapagliflozin. |
Dipyridamole | Dipyridamole The risk or severity of adverse effects can be increased when Dipyridamole is combined with Dapagliflozin. |
Isoxsuprine | Isoxsuprine The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Isoxsuprine. |
Vinblastine | Vinblastine The metabolism of Dapagliflozin can be decreased when combined with Vinblastine. |
Ethacrynic Acid | Ethacrynic Acid The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Etacrynic acid. |
Metoprolol | Metoprolol The metabolism of Dapagliflozin can be decreased when combined with Metoprolol. |
Hydroxyzine | Hydroxyzine The metabolism of Dapagliflozin can be decreased when combined with Hydroxyzine. |
Thiothixene | Thiothixene The metabolism of Thiothixene can be decreased when combined with Dapagliflozin. |
Aspirin | Aspirin The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Dapagliflozin. |
Alprazolam | Alprazolam Alprazolam may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Temazepam | Temazepam Dapagliflozin may increase the excretion rate of Temazepam which could result in a lower serum level and potentially a reduction in efficacy. |
Triazolam | Triazolam Dapagliflozin may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy. |
Dicyclomine | Dicyclomine Dapagliflozin may increase the excretion rate of Dicyclomine which could result in a lower serum level and potentially a reduction in efficacy. |
Propantheline | Propantheline Dapagliflozin may increase the excretion rate of Propantheline which could result in a lower serum level and potentially a reduction in efficacy. |
Trimethoprim | Trimethoprim Trimethoprim may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Diltiazem | Diltiazem The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Dapagliflozin. |
Nifedipine | Nifedipine The metabolism of Dapagliflozin can be decreased when combined with Nifedipine. |
Timolol | Timolol The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Timolol. |
Verapamil | Verapamil The metabolism of Dapagliflozin can be decreased when combined with Verapamil. |
Atenolol | Atenolol The therapeutic efficacy of Atenolol can be increased when used in combination with Dapagliflozin. |
Pindolol | Pindolol The therapeutic efficacy of Pindolol can be increased when used in combination with Dapagliflozin. |
Cisplatin Injection | Cisplatin Injection The metabolism of Dapagliflozin can be decreased when combined with Cisplatin. |
Diflunisal | Diflunisal The metabolism of Dapagliflozin can be decreased when combined with Diflunisal. |
Piroxicam | Piroxicam Piroxicam may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Bumetanide | Bumetanide The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Bumetanide. |
Streptozocin | Streptozocin The metabolism of Dapagliflozin can be increased when combined with Streptozocin. |
Etoposide | Etoposide The metabolism of Etoposide can be decreased when combined with Dapagliflozin. |
Glyburide | Glyburide The metabolism of Dapagliflozin can be decreased when combined with Glyburide. |
Glipizide | Glipizide Dapagliflozin may increase the hypoglycemic activities of Glipizide. |
Indapamide | Indapamide The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Indapamide. |
Amoxicillin | Amoxicillin Dapagliflozin may increase the excretion rate of Amoxicillin which could result in a lower serum level and potentially a reduction in efficacy. |
Nafcillin Injection | Nafcillin Injection The metabolism of Dapagliflozin can be increased when combined with Nafcillin. |
Oxacillin Injection | Oxacillin Injection Dapagliflozin may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy. |
Pentoxifylline | Pentoxifylline The metabolism of Pentoxifylline can be decreased when combined with Dapagliflozin. |
Pentamidine Injection | Pentamidine Injection Dapagliflozin may increase the hypoglycemic activities of Pentamidine. |
Ceftriaxone Injection | Ceftriaxone Injection Dapagliflozin may increase the excretion rate of Ceftriaxone which could result in a lower serum level and potentially a reduction in efficacy. |
Labetalol | Labetalol The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Labetalol. |
Auranofin | Auranofin Dapagliflozin may increase the excretion rate of Auranofin which could result in a lower serum level and potentially a reduction in efficacy. |
Leuprolide Injection | Leuprolide Injection The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Leuprolide. |
Gemfibrozil | Gemfibrozil The metabolism of Dapagliflozin can be decreased when combined with Gemfibrozil. |
Guanabenz | Guanabenz The metabolism of Guanabenz can be decreased when combined with Dapagliflozin. |
Ceftazidime Injection | Ceftazidime Injection Dapagliflozin may increase the excretion rate of Ceftazidime which could result in a lower serum level and potentially a reduction in efficacy. |
Ketoprofen | Ketoprofen Dapagliflozin may increase the excretion rate of Ketoprofen which could result in a lower serum level and potentially a reduction in efficacy. |
Cefotetan Injection | Cefotetan Injection Dapagliflozin may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy. |
Pimozide | Pimozide The metabolism of Pimozide can be decreased when combined with Dapagliflozin. |
Enalapril | Enalapril The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Enalapril is combined with Dapagliflozin. |
Flurbiprofen | Flurbiprofen Flurbiprofen may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Amiodarone | Amiodarone The metabolism of Dapagliflozin can be decreased when combined with Amiodarone. |
Aztreonam Injection | Aztreonam Injection Dapagliflozin may increase the excretion rate of Aztreonam which could result in a lower serum level and potentially a reduction in efficacy. |
Buspirone | Buspirone Buspirone may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Lovastatin | Lovastatin The metabolism of Lovastatin can be decreased when combined with Dapagliflozin. |
Ciprofloxacin | Ciprofloxacin The metabolism of Dapagliflozin can be decreased when combined with Ciprofloxacin. |
Mesalamine | Mesalamine Mesalazine may increase the hypoglycemic activities of Dapagliflozin. |
Diclofenac | Diclofenac The metabolism of Diclofenac can be decreased when combined with Dapagliflozin. |
Fluoxetine | Fluoxetine The serum concentration of Dapagliflozin can be increased when it is combined with Fluoxetine. |
Nimodipine | Nimodipine The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Dapagliflozin. |
Interferon Alfa-2b Injection | Interferon Alfa-2b Injection The metabolism of Dapagliflozin can be decreased when combined with Interferon alfa-2b. |
Clozapine | Clozapine The metabolism of Dapagliflozin can be decreased when combined with Clozapine. |
Estazolam | Estazolam Dapagliflozin may increase the excretion rate of Estazolam which could result in a lower serum level and potentially a reduction in efficacy. |
Idarubicin | Idarubicin The metabolism of Dapagliflozin can be decreased when combined with Idarubicin. |
Ofloxacin | Ofloxacin The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Ofloxacin. |
Didanosine | Didanosine Dapagliflozin may increase the excretion rate of Didanosine which could result in a lower serum level and potentially a reduction in efficacy. |
Pentostatin Injection | Pentostatin Injection Dapagliflozin may increase the excretion rate of Pentostatin which could result in a lower serum level and potentially a reduction in efficacy. |
Benazepril | Benazepril The risk or severity of hypoglycemia can be increased when Benazepril is combined with Dapagliflozin. |
Etodolac | Etodolac Etodolac may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Felodipine | Felodipine The metabolism of Felodipine can be decreased when combined with Dapagliflozin. |
Fosinopril | Fosinopril The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Dapagliflozin is combined with Fosinopril. |
Nabumetone | Nabumetone The metabolism of Nabumetone can be decreased when combined with Dapagliflozin. |
Quinapril | Quinapril The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Dapagliflozin is combined with Quinapril. |
Ramipril | Ramipril The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Dapagliflozin is combined with Ramipril. |
Simvastatin | Simvastatin The metabolism of Dapagliflozin can be decreased when combined with Simvastatin. |
Amlodipine | Amlodipine The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Dapagliflozin. |
Teniposide Injection | Teniposide Injection The metabolism of Dapagliflozin can be decreased when combined with Teniposide. |
Lisinopril | Lisinopril The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Dapagliflozin is combined with Lisinopril. |
Oxaprozin | Oxaprozin Dapagliflozin may increase the excretion rate of Oxaprozin which could result in a lower serum level and potentially a reduction in efficacy. |
Atovaquone | Atovaquone The metabolism of Dapagliflozin can be decreased when combined with Atovaquone. |
Sotalol | Sotalol The risk or severity of hypoglycemia can be increased when Sotalol is combined with Dapagliflozin. |
Bisoprolol | Bisoprolol The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Bisoprolol. |
Zolpidem | Zolpidem The metabolism of Zolpidem can be decreased when combined with Dapagliflozin. |
Doxazosin | Doxazosin The metabolism of Dapagliflozin can be decreased when combined with Doxazosin. |
Terazosin | Terazosin The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Terazosin. |
Isradipine | Isradipine Isradipine may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Omeprazole | Omeprazole The metabolism of Dapagliflozin can be increased when combined with Omeprazole. |
Cisapride | Cisapride The metabolism of Dapagliflozin can be decreased when combined with Cisapride. |
Fluvastatin | Fluvastatin The metabolism of Dapagliflozin can be decreased when combined with Fluvastatin. |
Venlafaxine | Venlafaxine The metabolism of Dapagliflozin can be decreased when combined with Venlafaxine. |
Fluvoxamine | Fluvoxamine The metabolism of Dapagliflozin can be decreased when combined with Fluvoxamine. |
Nefazodone | Nefazodone The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Dapagliflozin. |
Lamotrigine | Lamotrigine Lamotrigine may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Losartan | Losartan The metabolism of Dapagliflozin can be decreased when combined with Losartan. |
Valacyclovir | Valacyclovir Dapagliflozin may increase the excretion rate of Valaciclovir which could result in a lower serum level and potentially a reduction in efficacy. |
Tramadol | Tramadol Tramadol may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Vinorelbine Injection | Vinorelbine Injection The metabolism of Dapagliflozin can be decreased when combined with Vinorelbine. |
Carboplatin Injection | Carboplatin Injection Dapagliflozin may increase the excretion rate of Carboplatin which could result in a lower serum level and potentially a reduction in efficacy. |
Moexipril | Moexipril The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Dapagliflozin is combined with Moexipril. |
Lansoprazole | Lansoprazole The metabolism of Dapagliflozin can be decreased when combined with Lansoprazole. |
Ifosfamide Injection | Ifosfamide Injection The metabolism of Dapagliflozin can be decreased when combined with Ifosfamide. |
Nicardipine | Nicardipine The metabolism of Dapagliflozin can be decreased when combined with Nicardipine. |
Bupropion | Bupropion The metabolism of Dapagliflozin can be decreased when combined with Bupropion. |
Ticlopidine | Ticlopidine The metabolism of Dapagliflozin can be decreased when combined with Ticlopidine. |
Saquinavir | Saquinavir The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Saquinavir. |
Nisoldipine | Nisoldipine Nisoldipine may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Lamivudine | Lamivudine Dapagliflozin may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy. |
Riluzole | Riluzole The metabolism of Riluzole can be decreased when combined with Dapagliflozin. |
Amifostine Injection | Amifostine Injection The risk or severity of adverse effects can be increased when Amifostine is combined with Dapagliflozin. |
Acarbose | Acarbose Dapagliflozin may increase the hypoglycemic activities of Acarbose. |
Glimepiride | Glimepiride Dapagliflozin may increase the hypoglycemic activities of Glimepiride. |
Gemcitabine Injection | Gemcitabine Injection Dapagliflozin may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy. |
Indinavir | Indinavir The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Indinavir. |
Ritonavir | Ritonavir The serum concentration of Dapagliflozin can be increased when it is combined with Ritonavir. |
Cidofovir Injection | Cidofovir Injection Dapagliflozin may increase the excretion rate of Cidofovir which could result in a lower serum level and potentially a reduction in efficacy. |
Meropenem Injection | Meropenem Injection Dapagliflozin may increase the excretion rate of Meropenem which could result in a lower serum level and potentially a reduction in efficacy. |
Clomipramine | Clomipramine The metabolism of Clomipramine can be decreased when combined with Dapagliflozin. |
Zafirlukast | Zafirlukast The metabolism of Dapagliflozin can be decreased when combined with Zafirlukast. |
Fosfomycin | Fosfomycin Dapagliflozin may increase the excretion rate of Fosfomycin which could result in a lower serum level and potentially a reduction in efficacy. |
Mirtazapine | Mirtazapine The metabolism of Mirtazapine can be decreased when combined with Dapagliflozin. |
Trandolapril | Trandolapril The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Dapagliflozin is combined with Trandolapril. |
Topiramate | Topiramate Dapagliflozin may increase the excretion rate of Topiramate which could result in a lower serum level and potentially a reduction in efficacy. |
Zileuton | Zileuton The metabolism of Zileuton can be decreased when combined with Dapagliflozin. |
Valsartan | Valsartan The metabolism of Dapagliflozin can be decreased when combined with Valsartan. |
Insulin Lispro Injection | Insulin Lispro Injection Dapagliflozin may increase the hypoglycemic activities of Insulin lispro. |
Pramipexole | Pramipexole Pramipexole may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Donepezil | Donepezil The metabolism of Dapagliflozin can be decreased when combined with Donepezil. |
Nelfinavir | Nelfinavir The metabolism of Dapagliflozin can be decreased when combined with Nelfinavir. |
Azithromycin | Azithromycin The metabolism of Dapagliflozin can be decreased when combined with Azithromycin. |
Carvedilol | Carvedilol The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Carvedilol. |
Nilutamide | Nilutamide The metabolism of Dapagliflozin can be decreased when combined with Nilutamide. |
Flutamide | Flutamide The metabolism of Flutamide can be decreased when combined with Dapagliflozin. |
Selegiline | Selegiline Selegiline may increase the orthostatic hypotensive activities of Dapagliflozin. |
Bicalutamide | Bicalutamide The metabolism of Dapagliflozin can be decreased when combined with Bicalutamide. |
Sertraline | Sertraline The metabolism of Dapagliflozin can be decreased when combined with Sertraline. |
Propafenone | Propafenone The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Propafenone. |
Letrozole | Letrozole The metabolism of Dapagliflozin can be decreased when combined with Letrozole. |
Irbesartan | Irbesartan The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Irbesartan. |
Tamsulosin | Tamsulosin The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Tamsulosin. |
Ropinirole | Ropinirole The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Ropinirole. |
Quetiapine | Quetiapine The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Quetiapine. |
Cetirizine | Cetirizine Dapagliflozin may increase the excretion rate of Cetirizine which could result in a lower serum level and potentially a reduction in efficacy. |
Paroxetine | Paroxetine The metabolism of Dapagliflozin can be decreased when combined with Paroxetine. |
Tolcapone | Tolcapone The metabolism of Dapagliflozin can be decreased when combined with Tolcapone. |
Citalopram | Citalopram The metabolism of Dapagliflozin can be decreased when combined with Citalopram. |
Capecitabine | Capecitabine The metabolism of Dapagliflozin can be decreased when combined with Capecitabine. |
Efavirenz | Efavirenz The metabolism of Dapagliflozin can be decreased when combined with Efavirenz. |
Abacavir | Abacavir Dapagliflozin may increase the excretion rate of Abacavir which could result in a lower serum level and potentially a reduction in efficacy. |
Sildenafil | Sildenafil The metabolism of Dapagliflozin can be decreased when combined with Sildenafil. |
Pioglitazone | Pioglitazone Dapagliflozin may increase the hypoglycemic activities of Pioglitazone. |
Celecoxib | Celecoxib The metabolism of Dapagliflozin can be decreased when combined with Celecoxib. |
Rosiglitazone | Rosiglitazone The metabolism of Dapagliflozin can be decreased when combined with Rosiglitazone. |
Tolterodine | Tolterodine Tolterodine may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Thalidomide | Thalidomide The risk or severity of adverse effects can be increased when Thalidomide is combined with Dapagliflozin. |
Oseltamivir | Oseltamivir Dapagliflozin may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy. |
Balsalazide | Balsalazide Balsalazide may increase the hypoglycemic activities of Dapagliflozin. |
Nateglinide | Nateglinide Dapagliflozin may increase the hypoglycemic activities of Nateglinide. |
Galantamine | Galantamine The metabolism of Dapagliflozin can be decreased when combined with Galantamine. |
Rabeprazole | Rabeprazole The metabolism of Dapagliflozin can be decreased when combined with Rabeprazole. |
Terbinafine | Terbinafine The metabolism of Dapagliflozin can be decreased when combined with Terbinafine. |
Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists